Metabolic and nutritional approach of lipodystrophy in the use of antiretroviral therapy
Keywords:
Lipodystrophy, Nutrition, Antiretroviral therapy, highly activeAbstract
The highly active antiretroviral therapy used against Human Immunodeficiency Virus provides an improvement in laboratory and clinical findings of patients with Acquired Immunodeficiency Syndrome. However, metabolic and morphologic disturbances associated with the therapy are being investigated. The drawn out use of these therapy has an important impact on the nutritional status of the patients. Before the use of this therapy, weight loss and malnutrition caused by opportunistic infections were the biggest nutritional problems. Nowadays the main discussion points are the resulting metabolic and morphologic complications, among them lipodystrophy with dyslipidemia, insulin resistance, osteopenia and altered distribution of body fat, thus increasing the risk of cardiovascular diseases. Nutrition plays an essential role in supporting the health of these patients, integrating the multidisciplinary teams, improving antiretroviral therapy adherence rates and disease prognosis. However, in order to better understand the therapy, the side effect rates and the nutritional profile of these patients on the short and long run, it is vital to study this subject more deeply to obtain perspectives of a safer therapeutic regimen within its methodological scope, improving the quality of life of these patients.
References
United Nations Programme on HIV/AIDS. AIDS epidemic Update: special report on HIV/AIDS. Geneva: WHO; 2006.
Brasil. Ministério da Saúde. DST/AIDS: AIDS em números [acesso 2007 fev 22]. Disponível em: <http://www.aids.gov.br/data/Pages/LUMIS13F4BF21PTBRIE.htm>.
Brasil. Ministério da Saúde. DST/AIDS: Epidemiologia [acesso 2007 fev 22]. Disponível em: <http://www.aids.gov.br/data/Pages/LUMISD3352823PTBRIE.htm>.
Oliveira S, Lins D. Lipodistrofia relacionada à síndrome de imunodeficiência adquirida (AIDS). In: Bandeira F, Macedo G, Caldas G, Griz L, Faria MS. Endocrinologia e diabetes. Rio de Janeiro: Medsi; 2003. p.1018-22.
Rang HP, Dale MM, Ritter JM. Farmacologia. 4a. ed. Rio de Janeiro: Guanabara Koogan; 2001. p.595-604.
Scevola D, Matteo DA, Uberti F, Minoia G, Poletti F, Faga A. Reversal of cachexia in patients treated with potent antiretroviral. AIDS Read. 2000; 10(6): 365-75.
Shevitz AH, Knox TA. Nutrition in the era of highly active antiretroviral therapy. Clin Infect Dis. 2001; 32(12):1769-75.
Brasil. Ministério da Saúde. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV. Brasília; 2003.
Fernandes APM, Sanches SER, Porfírio E, Machado AA, Donadi EA. Lipodistrofia em portadores do HIV. J Bras AIDS. 2005; 6(3):93-140.
World Health Organization. Terapia anti-retroviral para o tratamento da infecção pelo HIV [acesso 2007 fev 22]. Disponível em: <http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2004.329_por_chap11.pdf>.
Valente AMM, Reis AF, Machado DM, Succi RCM, Chacra AR. HIV lipodystrophy syndrome. Arq Bras Endocrinol Metab. 2005; 49(6):871-81.
American Dietetic Association. Position of the american dietetic association and dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc. 2004; 104(9):1425-41.
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(1):48-62.
Salyer J, Lyon DE, Settle J, Elswick RK, Rackley D. Coronary heart disease risks and lifestyle behaviors in persons with HIV infection. J Assoc Nurses AIDS Care. 2006; 17(3):3-17.
Currier J, Carpenter C, Daar E, Kotler D, Wanke C. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002; 12(3):114-25.
Castellar E, Vilar L. Distúrbios endócrinos e metabólicos na AIDS. In: Vilar L, Castellar E, Moura E, Leal E, Machado AC, Teixeira L, et al. Endocrinologia clínica. 2a. ed. Rio de Janeiro: Medsi; 2001. p.871-82.
Montessori V, Press N, Harris M, Akagi L, Montaner JSG. Adverse effect of antiretroviral therapy for HIV infection. Can Med Assoc J. 2004; 170(2):229-38.
Tsiodras S, Mantzoros C, Hammer S, Samore M. Effects of protease inhibitors on hyperglycemia, hiperlipidemia ande lipodystrophy- a 5 years cohort study. Arch Int Med. 2000; 160(13):2050-6.
Madge S, Kinloch-de-Loes S, Mercey D, Johnson MA, Weller IVD. Lipodystrophy in patients naive to HIV protease inhibitors [correspondence]. AIDS. 1999; 13(6):735-7.
Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm D, et al. A syndrome of peripheral lipodystrophy, hiperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998; 12(7):F51-8.
Haugaard SB, Andersen O, Storgaard H, Dela F, Holst JJ, Iversen J, et al. Insulin secretion in lipodystrophic hiv patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells. Am J Physiol Endocrinol Metab. 2004; 287(4):E677-E85.
Currier JS, Havlir DV. Complication of HIV disease and antiretroviral therapy. Top HIV Med. 2004; 12(1):31-9.
Sweet DE. Metabolic complication of antiretroviral therapy. Top HIV Med. 2005; 13(2):70-4.
Lima GAB, Verdeal JCR, Farias MLF. Osteonecrosis in patients with acquired immunodeficiency syndrome (AIDS): Report of Two Cases and Review of Literature. Arq Bras Endocrinol Metab. 2005; 49(6):996-9.
Roca B. Trastornos metabólicos relacionados con el VIH y el tratamiento antirretroviral. An Med Interna. 2003; 20(11):37-45.
Luis DA, Bachiller P, Izaola O, Bouza JME, Aller R. Estado nutricional de pacientes infectados por el virus de la inmunodeficiencia humana (VIH). An Med Interna. 2001; 18(12):619-23.
Corcoran C, Grinspoon S. Treatments for wasting in patients with the acquired immunodeficiency syndrome. N Eng J Med. 1999; 340(22):1740-50.
Highleyman L. Nutrition and HIV. Bolletin of experimental treatments for AIDS. Winter. Foundation San Francisco. AIDS. 2006; 18(2):18-32.
Jaime PC, Florindo AA, Latorre MRDO, Brasil BG, Santos ECM, Segurado AAC. Prevalência de sobrepeso e obesidade abdominal em indivíduos portadores de HIV/AIDS, em uso de terapia antiretroviral de alta potência. Rev Bras Epidemiol. 2004; 7(1):65-72.
Coppini LZ, Ferrini M T. Síndrome da imunodeficiência adquirida (AIDS). In: Cuppari L, organizador. Guia de nutrição: nutrição clínica no adulto. Barueri: Manole; 2002. p.235-47.
Eldridge B. Cuidado nutricional na infecção por HIV e AIDS. In: Mahan LK, Escott-Stump S. Krause, alimentos e dietoterapia. 8a. ed. São Paulo: Roca; 1998. p.848-59.
World Health Organization. Reports of a technical consultation. Nutrient requeriments for people living with HIV/AIDS. Geneva: WHO; 2003.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST/AIDS. Manual clínico de alimentação e nutrição na assistência a adultos infectados pelo HIV. Brasília: Ministério da Saúde; 2006.
Polo R. Manual de nutrición y SIDA. 3a. ed. Madrid: Fundación Wellcome España; 2002.
Martin JM, González AA, Aguayo PS. Pérdida de peso en el paciente VIH. In: Díaz JP, Emilio LP, Román AR. La infección por el VIH: Guía práctica. 2a. ed. Andalucía: Sociedad Andaluza de Enfermedades Infecciosas; 2000. p.221-32.
Food and Nutrition Technical Assistance Project, Academy for Educational Development. HIV/AIDS: a guide for nutritional care and support. 2nd ed. Washington (DC); 2004. p.10-7.
NAM Nutrition. 7th ed. London: NAM, 2006 [cited 2007 Nov 14]. Available from: <http://www.aidsmap.com/publications/infoseries/nutrition.pdf>.
Nicholson M. Diet & lipodystrophy. In: Positively Aware. Test Positive Aware Network. 2004; 15(3): 23-5.
Dreyfuss ML, Fawzi WW. Micronutrients and vertical transmission of HIV-1. Am J Clin Nutr. 2002; 75(6): 959-70.
Heaney RP, Rafferty K. Carbonated beverages and urinary calcium excretion. Am J Clin Nutr. 2001; 74(3):343-47.
Mondy K, Tebas P. Emerging bone problems in patients infected with human Immunodeficiency virus. Clin Infect Dis. 2003; 36(2):S101-5.
Arey BD, Bela MW. The role of exercise in the prevention and treatment of wasting in acquired immunedeficiency syndrome. J Assoc Nurses AIDS Care. 2002; 13(1):29-49.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Claudia Daniele Tavares DUTRA, Rosana Maria Feio LIBONATI
This work is licensed under a Creative Commons Attribution 4.0 International License.
